| |
TPS
™ IS A TOOL FOR THE EARLY DETECTION OF CHANGES IN DISEASE STATUS:
|
| a)
Measures tumor cell activity. |
| b) Has a high sensitivity
for metastatic disease. |
| c) Indicates changes in the
disease state earlier than clinical criteria (UICC). |
| |
| TPS
™ SUPPORTS THERAPEUTICAL DECISIONS TO OPTIMISE PATIENT MANAGEMENT
FOR: |
| a) Improved patient outcome.
|
| b) Improved quality of life. |
| c) Improved cost/benefit ratio. |
| |
| TPS
™ PROVIDES EARLIER FEEDBACK ON THE EFFICACY OF TREATMENT RESPONSE
THAN MARKERS FOR TUMOR BURDEN: |
| a) Provides early confirmation
of the efficacy of treatment. |
| b) Gives an early indication
of treatment failure. |
|
